Article
CTNNB1 mutation suppresses infiltration of immune cells in hepatocellular carcinoma through miRNA-mediated regulation of chemokine expression.
International immunopharmacology - 1 Dec 2020
Xiao Xuelian, Mo Huanye, Tu Kangsheng
Abstract excerpt
Mutations in the CTNNB1 gene in hepatocellular carcinoma (HCC) are related to immune exclusion, and HCC patients with CTNNB1 mutations tend to be primarily resistant to anti-PD1 therapy. However, systemic evaluation of immune cell infiltration in HCC with mutant CTNNB1 is lacking, and the mechanism of immune exclusion resulting from CTNNB1 mutations remains unclear. Based on CTNNB1 mutation status in HCC, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
